Formation of biliary thrombi in protoporphrin‐induced cholestasis in perfused rat liver

The effect of bile acids on the formation of biliary thrombi in protoporphyrin‐induced cholestasis was determined by perfusing isolated rat livers with taurocholate, chenodeoxycholate and ursodeoxycholate with and without protoporphyrin. Protoporphyrin‐induced reduction of bile flow was similar in the presence of each bile acid. The cholestasis was greater at high doses (2,000 to 10,885 nmol) than at low doses (1,500 nmol) of protoporphyrin, unrelated to the amount of lactate dehydrogenase released into the perfusate, and it was not altered by increasing bile acid infusions. Bile acid excretion was inhibited by high protoporphyrin doses. Periportal birefringent pigment deposits were seen in canaliculi and ductules when the biliary protoporphyrin concentration exceeded 161 nmol/ml, 345 nmol/ml and 1,036 nmol/ml for ursodeoxycholate, chenodeoxycholate and taurocholate, respectively; or, when the protoporphyrin (nanomole) to bile acid (micromole) ratio exceeded 3.23, 7.03 and 23.43, respectively. The maximal ratio of ductular deposits to portal tract deposits examined was 0.9. Electron microscopy showed these deposits were associated with canalicular thrombi. Thus, biliary thrombi were produced by infusion of bile acids and protoporphyrin. The occurrence of thrombi varied with bile acid structure. Explanations for this finding are speculative. The presence of periportal thrombi, however, did not influence the degree of functional cholestasis.(HEPATOLOGY 1990; 11:757‐763.)

[1]  H. Kaufmann,et al.  The Liver: Biology and Pathobiology, 2nd ed , 1989 .

[2]  J. Bloomer,et al.  Hepatic and bile porphyrins in patients with protoporphyria and liver failure. , 1988, Gastroenterology.

[3]  J. Bloomer The liver in protoporphyria , 1988, Hepatology.

[4]  M. C. Park,et al.  Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. , 1988, Gastroenterology.

[5]  J. Marin,et al.  Effect of bile acids on hepatic protoporphyrin metabolism in perfused rat liver. , 1987, Gastroenterology.

[6]  R. Lee,et al.  Structure-function relationships of protoporphyrin-induced liver injury. , 1984, Archives of pathology & laboratory medicine.

[7]  H. Zimmerman,et al.  Cholestasis Induced by Estradiol‐17β‐D‐Glucuronide: Mechanisms and Prevention by Sodium Taurocholate , 1984, Hepatology.

[8]  M. Poh-Fitzpatrick,et al.  Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria. , 1983, The Journal of clinical investigation.

[9]  D. M. Burchfield,et al.  Effects of 2-n-butyl-methylenedioxyindene on skeletal muscle mechanics and energetics. , 1982, The American journal of physiology.

[10]  J. Bloomer,et al.  Evidence that hepatic crystalline deposits in a patient with protoporphyria are composed of protoporphyrin. , 1982, Gastroenterology.

[11]  R. Lee,et al.  Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver. , 1981, The Journal of clinical investigation.

[12]  D. Macdonald,et al.  The histopathology and ultrastructure of liver disease in erythropoietic protoporphyria , 1981, The British journal of dermatology.

[13]  G. Kakis,et al.  Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats. , 1978, Gastroenterology.

[14]  J. Dietschy,et al.  Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total bile acids in bile. , 1978, Journal of lipid research.

[15]  R. Ockner,et al.  Bile secretion in selective biliary obstruction. Adaptation of taurocholate transport maximum to increased secretory load in the rat. , 1977, Gastroenterology.

[16]  T. Layden,et al.  Taurolithocholate-induced cholestasis: taurocholate but not dehydrocholate, reverses cholestasis and bile canalicular membrane injury. , 1977, Gastroenterology.

[17]  B. Priestly,et al.  Intrahepatic cholestasis induced by drugs and chemicals. , 1976, Pharmacological reviews.

[18]  H. Hönigsmann,et al.  Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals. , 1975, The Journal of investigative dermatology.

[19]  J. Bloomer,et al.  Hepatic disease in erythropoietic protoporphyria. , 1975, The American journal of medicine.

[20]  A. Matilla,et al.  A light and electron microscopic study of the liver in case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice , 1974, Journal of clinical pathology.

[21]  J. Bloomer,et al.  Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits. , 1974, Gastroenterology.

[22]  S. Piomelli,et al.  A micromethod for free erythrocyte porphyrins: the FEP test. , 1973, The Journal of laboratory and clinical medicine.

[23]  V. Desmet Morphologic and histochemical aspects of cholestasis. , 1972, Progress in liver diseases.

[24]  H. Popper,et al.  Pathophysiology of cholestasis. , 1970, Human pathology.

[25]  C J Watson,et al.  Enterohepatic Circulation and Conversion of Protoporphyrin to Bile Pigment in Man∗ , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  K. Yamasaki,et al.  ENZYMATIC DETERMINATION AND THIN-LAYER CHROMATOGRAPHY OF BILE ACIDS IN BLOOD. , 1964, Journal of biochemistry.